Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2022-06-22 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
FOURTH EXTENSION OF PLACING PERIOD
Capital/Financing Update Classification · 95% confidence The document is an announcement from Reliance Global Holdings Limited regarding the fourth extension of the placing period for a note issuance. It references previous announcements and details the extension of the closing date for the placing agreement. The document is relatively short (2757 characters) and primarily serves as an update on financing activity rather than containing financial statements or detailed financial analysis. There is no indication of it being a full financial report, audit, or regulatory filing beyond this update. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-06-22 English
PROFIT WARNING
Regulatory Filings Classification · 95% confidence The document is titled 'PROFIT WARNING' and is an announcement made pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. It provides a preliminary assessment of the company's expected decrease in profit for the fiscal year ended 31 March 2022 based on unaudited management accounts. The announcement explicitly states that the final annual results will be disclosed later and that the current information is preliminary and unaudited. The document length is 3245 characters, which is relatively short and consistent with an announcement rather than a full report. There are no detailed financial statements or comprehensive analysis present, only a summary of expected financial performance and cautionary advice to investors. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement providing material information but not the full annual report or earnings release itself.
2022-06-17 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from Reliance Global Holdings Limited notifying the market and shareholders of an upcoming board meeting scheduled for 28 June 2022. The purpose of the meeting includes approving the annual results for the year ended 31 March 2022. The document does not contain any financial data, detailed results, or analysis itself, but merely informs about the meeting date and agenda. It is under 5,000 characters and serves as a notification rather than the actual report or results. Therefore, it fits the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2022-06-16 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the establishment of a new direct business channel in the United Kingdom. It does not contain financial statements, audit information, or detailed management discussion. It is not a report or transcript but an announcement about a strategic business development. The document is relatively short (2273 characters) and serves as a public disclosure of a business update. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other specific categories.
2022-06-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities, specifically focusing on authorized and issued shares of Sisram Medical Ltd. It details share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is structured as a regulatory submission with no financial statements or management discussion. It is a regulatory compliance filing related to share capital movements rather than a financial report, earnings release, or management report. The document length is 4430 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-06-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on authorized and issued share capital, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content includes detailed tables of share capital movements, types of shares, and confirmations by an executive director. This type of document is a regulatory submission related to share capital changes and securities movements, not a full financial report or earnings release. It is not an announcement of a report but a substantive regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-06-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.